[ET Net News Agency, 20 January 2026] INNOVENT BIO (01801) fell 3% to HK$82.8.
It hits an intra-day low of HK$82.75, dipping below the 20-D SMA of HK$84.518, and an intra-day high of HK$86.05. The total shares traded was 5.67 million, with a value of HK$476.8m. The active buy/sell ratio is 39:61, with net selling turnover of HK$102.61m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$29.58m, with volume weighted average price of HK$84.099. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$12.86m, with volume weighted average price of HK$83.867. The stock has fallen a combined 7.5% over the past 2 consecutive trading days.
The Hang Seng Index now fell 72 points, or 0.3% to 26,491; the Hang Seng China Enterprises Index now fell 37 points, or 0.4% to 9,097.
Basic Information| Nominal | 82.800 | % Chg | -2.99% |
| High | 86.050 | Low | 82.750 |
| Shares Tr | 5.67m | Turnover | 476.8m |
| 10-D SMA | 88.220 | %H.V | 40.051 |
| 20-D SMA | 84.518 | VWAP | 84.076 |
| 50-D SMA | 87.026 | RSI14 | 42.152 |
Status: Dipping below the 20-D SMA, active buy/sell ratio is 39:61, with net selling turnover of HK$102.61m, falling a combined 7.5% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOVENT BIO (01801) | 82.80 | -2.99 |
| CSPC PHARMA (01093) | 9.70 | -0.41 |
| SINO BIOPHARM (01177) | 6.48 | -0.61 |
| HENGRUI PHARMA (01276) | 73.85 | -3.97 |
| WUXI BIO (02269) | 37.18 | -1.80 |
| WUXI APPTEC (02359) | 113.30 | -4.47 |
| ZIJIN MINING (02899) | 39.58 | +0.66 |
| HANSOH PHARMA (03692) | 40.16 | -2.71 |
| BEONE MEDICINES (06160) | 197.30 | -1.55 |
| AKESO (09926) | 116.40 | -0.77 |
(ed)
